hello

AFFÄRSIDÉ

Integrum är ett medicintekniskt bolag som utvecklar och marknadsför system för skelettförankrade proteser.

Bransch: Sjukvård
Marknad: First North
Tickerkod: INTEG B
Certified Adviser: Erik Penser Bank

WEBBPLATS

OMSÄTTNING OCH AKTIEKURS

I grafen visas aktiekursutveckling och omsättning för valt bolag. Informationen är fördröjd med 15 min.

Omsättning
Aktuell Kurs
Utvecklingen i dag
Pressreleaser | 26 Jan 2023 | Integrum

Integrum AB: Integrum appoints Chief…

Mats Dotevall has over 30 years of experience in management, product development, and business development within the medtech industry. Former positions include senior management roles at GN ReSound in the…

Läs hela nyheten
Pressreleaser | 20 Jan 2023 | Integrum

Integrum AB: Integrum appoints Director…

Annika Fahlén has vast experience in the field of Quality Assurance and Regulatory Affairs working at Mölnlycke, Getinge, Qing and Abigo. She will join Integrum from a position as Regulatory…

Läs hela nyheten
Pressreleaser | 19 Jan 2023 | Integrum

Integrum AB: Integrum's CFO will leave…

”Dennis has played an important role in the development of Integrum’s business and has been an appreciated leader during a transformative time for the company. I want to express our…

Läs hela nyheten
Analyser | 2 Dec 2022 | Integrum

Redeye: Integrum Q2 - Preparing for the…

Redeye is encouraged by Integrum’s strong quarterly sales, and we argue that the company seems to continue delivering well on its intensified US commercial efforts. We make no particular estimate…

Läs hela nyheten
Pressreleaser | 1 Dec 2022 | Integrum

Integrum AB: NYU Langone Health…

NYU Langone is ranked among the top five hospitals in the US for orthopedic surgery, according to the U.S. News & World Report. The department employs more than 200 orthopedic…

Läs hela nyheten
Rapporter | 1 Dec 2022 | Integrum

Integrum AB: Delårsrapport maj - okt…

Andra kvartalet 2022/23 (aug-okt) Nettoomsättning uppgick till TSEK 20 226 (11 883), vilket är en ökning med 70% jämfört med motsvarande period föregående år. Tillväxten på den amerikanska marknaden är 78%…

Läs hela nyheten
Rapporter | 1 Dec 2022 | Integrum

Integrum AB: Interim report May - Oct…

The period AUG 1st 2022 – Oct 31st 2022 ▪    Net sales amountedTSEK 20 226 (11 883), which is an increase of 70% compared with the corresponding period last year.…

Läs hela nyheten
Pressreleaser | 30 Nov 2022 | Integrum

Integrum AB: Integrum provides an update…

e-OPRA[TM] Implant System The clinical development of e-OPRA™ Implant System focuses not only on providing prosthesis users with the benefits of a bone-anchored implant solution but also on the possibilities…

Läs hela nyheten
Pressreleaser | 17 Nov 2022 | Integrum

Integrum AB: Integrum presents health…

The ”Cost-effectiveness analysis of osseointegrated prostheses for transfemoral amputation” poster was presented by Jeff Voigt, MBA, MPH, the lead author, at the 99th Annual ACRM conference on November 9th, 2022.…

Läs hela nyheten
Pressreleaser | 2 Nov 2022 | Integrum

Integrum AB: The University Hospital of…

The procedure was performed at the Department of Plastic, Hand and Reconstructive Surgery at the University Hospital of Regensburg. Founded in 1245 and built on the site of a 2[nd]…

Läs hela nyheten

Kommande händelser

1 Mar 2023 | Kvartalsrapport 2023-Q3
8 Jun 2023 | Bokslutskommuniké 2023